Login / Signup
Reply to Roesler et al. concerning the MEVITEM trial.
Didier Frappaz
Marc Barritault
Published in:
Neuro-oncology (2022)
Keyphrases
</>
phase iii
study protocol
phase ii
clinical trial
randomized controlled trial
open label
double blind
placebo controlled